Skip to content
HeyJared

Amy Fix

Reporter · US

Indexed articles, last 90 days
1
Latest publication
Jul 14, 2026
Outlet visibility, for Mondaq
Top 500K sites
Earliest in this view
Jul 14, 2026
The latest indexed work is over 30 days old. There may be a gap in what we hold.

Latest articles

  1. Article · Jul 14, 2026 · Amy Fix

    The $107.5 Million Dosage Gap: Enablement Lessons From Wyeth v. AstraZeneca (opens the original)

    Excerpt · Critical tone · English

    Read excerpt

    On July 9, the federal circuit issued a decision in Wyeth LLC v. AstraZeneca Pharmaceuticals LP, affirming a district court's grant of judgment as a matter of law ("JMOL") invalidating Wyeth's asserted claims in U.S. Patents 10,603,314 and 10,596,162 for lack of enablement under 35 U.S.C. § 112(a). The case arose from Wyeth's infringement suit against AstraZeneca over Tagrisso(R) (osimertinib), an irreversible EGFR inhibitor used to treat gefitinib/erlotinib-resistant non-small cell lung cancer.

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

Top 500K sites

For Mondaq, the outlet · Measured Aug 1, 2026

Website popularity band, not a count of readers or article views.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about Amy Fix